Hongzhou Cai
Jiangsu Cancer Hospital(CN)Nanjing Medical University(CN)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Epigenetics and DNA Methylation, CRISPR and Genetic Engineering, Cancer Genomics and Diagnostics, MicroRNA in disease regulation
Most-Cited Works
- → Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review(2016)230 cited
- → Exosomal MicroRNA-9-3p Secreted from BMSCs Downregulates ESM1 to Suppress the Development of Bladder Cancer(2019)115 cited
- → Comparison between transrectal and transperineal prostate biopsy for detection of prostate cancer: a meta-analysis and trial sequential analysis(2017)113 cited
- → miR‐152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines(2013)76 cited
- → Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta‐analysis of 11 cohort studies(2014)75 cited
- → Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer(2022)71 cited
- → miR-154 inhibits EMT by targeting HMGA2 in prostate cancer cells(2013)69 cited
- → miR-154 inhibits prostate cancer cell proliferation by targeting CCND2(2013)62 cited
- → A Functional Variant in the MTOR Promoter Modulates Its Expression and Is Associated with Renal Cell Cancer Risk(2012)52 cited
- → Genetic polymorphisms in HIF1A are associated with prostate cancer risk in a Chinese population(2012)49 cited